The recent market downturn has been especially hard on riskier stocks—and all three of these ETFs are down considerably from their 2021 highs. But the best of the stocks these ETFs hold are at the forefront of innovative industries or segments that still have considerable… Read More
Exchange-traded funds have traditionally offered investors three main advantages: ease of trading, low fees, and transparency. We still believe passively managed ETFs—which simply track benchmark indexes—do the best job of meeting those goals. However, actively managed ETFs, where fund managers tinker with their holdings to… Read More
Drug stocks can offer lots of potential for investor profit—but there are three major hurdles most drug makers face.
Investors often comment that we sometimes differ with the mainstream view on which stocks make good investments. That’s especially true with drug stocks.
The… Read More
Please take note of our new weekly feature: Every Friday, we’re going to bring you our latest advice and stock research on companies from our weekly Inner Circle Q&A service, in which I answer specific investment questions from our members.
I hope you enjoy and… Read More